These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 11172535)

  • 21. Treatment of acute promyelocytic leukaemia.
    Fenaux P; Chomienne C; Degos L
    Best Pract Res Clin Haematol; 2001 Mar; 14(1):153-74. PubMed ID: 11355929
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Expression of interleukin-8 and its receptor in acute promyelocytic leukemia under all-trans retinoic acid treatment].
    Zeng H; Zhang X; Tao R
    Zhonghua Xue Ye Xue Za Zhi; 1998 Jul; 19(7):346-9. PubMed ID: 11189515
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Severe hemorrhagic complications during remission induction therapy for acute promyelocytic leukemia: incidence, risk factors, and influence on outcome.
    Yanada M; Matsushita T; Asou N; Kishimoto Y; Tsuzuki M; Maeda Y; Horikawa K; Okada M; Ohtake S; Yagasaki F; Matsumoto T; Kimura Y; Shinagawa K; Iwanaga M; Miyazaki Y; Ohno R; Naoe T
    Eur J Haematol; 2007 Mar; 78(3):213-9. PubMed ID: 17241371
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acute promyelocytic leukemia: recent advances in diagnosis and management.
    Lo-Coco F; Ammatuna E; Montesinos P; Sanz MA
    Semin Oncol; 2008 Aug; 35(4):401-9. PubMed ID: 18692690
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction of differentiation of acute promyelocytic leukemia cells by a cytidine deaminase-resistant analogue of 1-beta-D-arabinofuranosylcytosine, 1-(2-deoxy-2-methylene-beta-D-erythro-pentofuranosyl)cytidine.
    Niitsu N; Ishii Y; Matsuda A; Honma Y
    Cancer Res; 2001 Jan; 61(1):178-85. PubMed ID: 11196157
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The PML-RAR alpha transcript in long-term follow-up of acute promyelocytic leukemia patients.
    Gameiro P; Vieira S; Carrara P; Silva AL; Diamond J; Botelho de Sousa A; Mehta AB; Prentice HG; Guimarães JE; Hoffbrand AV; Foroni L; Parreira A
    Haematologica; 2001 Jun; 86(6):577-85. PubMed ID: 11418366
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The biological characteristics of CD34+ CD2+ adult acute promyelocytic leukemia and the CD34 CD2 hypergranular (M3) and microgranular (M3v) phenotypes.
    Albano F; Mestice A; Pannunzio A; Lanza F; Martino B; Pastore D; Ferrara F; Carluccio P; Nobile F; Castoldi G; Liso V; Specchia G
    Haematologica; 2006 Mar; 91(3):311-6. PubMed ID: 16531253
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Microgranular acute promyelocytic leukemia presenting with leukopenia and an unusual immunophenotype.
    McDonnell MH; Smith ET; Lipford EH; Gerber JM; Grunwald MR
    Hematol Oncol Stem Cell Ther; 2017 Mar; 10(1):35-38. PubMed ID: 26806461
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induction of CXC and CC chemokines by all-trans retinoic acid in acute promyelocytic leukemia cells.
    Shibakura M; Niiya K; Niiya M; Asaumi N; Yoshida C; Nakata Y; Tanimoto M
    Leuk Res; 2005 Jul; 29(7):755-9. PubMed ID: 15927671
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment with all-trans retinoic acid and anthracycline monochemotherapy for children with acute promyelocytic leukemia: a multicenter study by the PETHEMA Group.
    Ortega JJ; Madero L; Martín G; Verdeguer A; García P; Parody R; Fuster J; Molines A; Novo A; Debén G; Rodríguez A; Conde E; de la Serna J; Allegue MJ; Capote FJ; González JD; Bolufer P; González M; Sanz MA;
    J Clin Oncol; 2005 Oct; 23(30):7632-40. PubMed ID: 16234524
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thrombosis during all-trans-retinoic acid therapy in a child with acute promyelocytic leukemia and factor VQ 506 mutation.
    Koçak U; Gürsel T; Oztürk G; Kantarci S
    Pediatr Hematol Oncol; 2000 Mar; 17(2):177-80. PubMed ID: 10734661
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Hypercalcemia associated with all-trans retinoic acid therapy for microgranular type acute promyelocytic leukemia].
    Hisatake J; Shimozuma J
    Rinsho Ketsueki; 2008 Jun; 49(6):408-12. PubMed ID: 18646608
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effect of additional chromosome abnormalities on the outcome of newly diagnosed acute promyelocytic leukemia treated with red arsenic sulfide and all trans-retinoic acid plus anthracyclin based protocol].
    Lu J; Jiang H; Jiang Q; Bao L; Lu XJ; Zhang Y; Lin W; Liu YR; Huang XJ; Jiang B
    Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(32):2254-7. PubMed ID: 19087672
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The pathophysiology and treatment of hemorrhagic syndrome of acute promyelocytic leukemia.
    Rodeghiero F; Castaman G
    Leukemia; 1994; 8 Suppl 2():S20-6. PubMed ID: 7815832
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cutaneous promyelocytic sarcoma at sites of vascular access and marrow aspiration. A characteristic localization of chloromas in acute promyelocytic leukemia?
    Sanz MA; Larrea L; Sanz G; Martín G; Sempere A; Gomis F; Martínez J; Regadera A; Saavedra S; Jarque I; Jiménez C; Cervera J; de La Rubia J
    Haematologica; 2000 Jul; 85(7):758-62. PubMed ID: 10897129
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Retinoid receptor expression and its correlation to retinoid sensitivity in non-M3 acute myeloid leukemia blast cells.
    Lehmann S; Paul C; Törmä H
    Clin Cancer Res; 2001 Feb; 7(2):367-73. PubMed ID: 11234892
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute promyelocytic leukemia: morphological and clinical features.
    Invernizzi R; Iannone AM; Bernuzzi S; D'Alessio A; Fiamenghi C; Ippoliti G; Scagliosi S; Ascari E
    Haematologica; 1993; 78(3):156-61. PubMed ID: 8375744
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of all-trans retinoic acid and arsenic trioxide on tissue factor expression in acute promyelocytic leukemia cells.
    Guo W; Wang H; Zhao W; Zhu J; Ju B; Wang X
    Chin Med J (Engl); 2001 Jan; 114(1):30-4. PubMed ID: 11779431
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Curative therapeutic approaches to APL.
    Tallmann MS
    Ann Hematol; 2004; 83 Suppl 1():S81-2. PubMed ID: 15124685
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute promyelocytic leukemia in children and adolescents.
    Stein EM; Tallman MS
    Acta Haematol; 2014; 132(3-4):307-12. PubMed ID: 25228556
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.